Immunotherapy in Early Stage Non-Small Cell Lung Cancer von Ramanarayanan, Jeyanthi, Krishnan, Ganapathy

Volltext

Targeted treatment of chronic myeloid leukemia: role of imatinib von Tamascar, Ila, Ramanarayanan, Jeyanthi

Volltext

Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients von Ramanarayanan, Jeyanthi, Dunford, Lauren M., Baer, Maria R., Sait, Sheila N.J., Lawrence, William, McCarthy, Philip L.

Volltext

PI CME driven interventions in an outpatient oncology practice to improve awareness and utilization of advanced care directives von Whitt, Elizabeth Ann, Copp, Monica, Smith, Doug, Bihl, Debbie ELAINE, Krishnan, Ganapathy S., Ramanarayanan, Jeyanthi, Daugherty, Stacie, Roach, Ralph W., VanDeusen, Jeffrey Bryan

Volltext

Acute drug induced hepatitis due to erlotinib von Ramanarayanan, Jeyanthi, Scarpace, Sarah L

Volltext

Review: hepatotoxicity and EGFR inhibition von Ramanarayanan, Jeyanthi, Krishnan, Ganapathy S

Volltext

Tumor Necrosis Factor Alpha (TNF-a) Blockade and Risk of Lymphoma: Systematic Review and Analysis of Literature von Ramanarayanan, Jeyanthi, Pahuja, Shalu, Czuczman, Myron S, Hernandez-Ilizaliturri, Francisco J.

Volltext

Effect of Renin Angiotensin System (RAS) Blockade on Hematological Parameters in Patients with Secondary Polycythemia (SP) Associated with Chronic Obstructive Pulmonary Disease (CO... von Ramanarayanan, Jeyanthi, Brodzik, Frank, Mehdi, Syed, Pasquale, Donald

Volltext

Pro-apoptotic therapy with the oligonucleotide Genasense (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumour activity of rituximab von RAMANARAYANAN, Jeyanthi, HERNANDEZ-ILIZALITURRI, Francisco J, CHANAN-KHAN, Asher, CZUCZMAN, Myron S

Volltext

Efficacy and Safety of Rituximab in Post Transplant Lymphoproliferative Disorders (PTLD): Pooled Analysis and Review of Literature von Ramanarayanan, Jeyanthi, Krishnan, Ganapathy S., Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Volltext

Individualized Dosing of Fludarabine (FLU) for Low Grade Lymphoproliferative Disorders Results in Administration of Less Medication with Fewer Infections and Equivalent Survival von Pasquale, Donald, Ramanathan, Nalini, Scarpace, Sarah L., Nguyen, Hung, Jackson, Amy I., Ramanarayanan, Jeyanthi

Volltext

Efficacy and Safety of Rituximab in the Treatment of Refractory/Relapsed Idiopathic Thrombocytopenic Purpura (ITP): Results of a Meta-Analysis of 299 Patients von Ramanarayanan, Jeyanthi, Brodzik, Frank, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

Volltext

In Vivo Downregulation of Bcl-2 by G3139 (G) Enhances Rituximab (R) Anti-Tumor Activity: Effect of Sequential Versus Concurrent G3139 Administration on Survival in a Lymphoma-Beari... von Ramanarayanan, Jeyanthi, Hernandez-Ilizaliturri, Francisco J., Czuczman, Myron S.

Volltext

Clonal evolution with + 11q 13, t(1;7) and t(1;4) at relapse in a patient with Ph positive acute lymphocytic leukemia (ALL) treated with single agent front line imatinib followed b... von Ramanarayanan, Jeyanthi, Mehdi, Syed, Brodzik, Frank, Pasquale, Donald

Volltext

BCNU toxicity presenting with a large pericardial and pleural effusion von Krishnan, Ganapathy S, Chaudhary, Vijay, Al-Janadi, Anas, Ramanarayanan, Jeyanthi, D'Silva, Karl J

Volltext

Autoimmune Disease (AD) in Patients with Myelodysplastic Syndrome (MDS): A Retrospective Single Institution Study von Ramanarayanan, Jeyanthi, Baer, Alan N., Battiwalla, Minoo, Ford, Laurie A., Wetzler, Meir, Baer, Maria R.

Volltext

Pro‐apoptotic therapy with the oligonucleotide Genasense TM (oblimersen sodium) targeting Bcl‐2 protein expression enhances the biological anti‐tumour activity of rituximab von Ramanarayanan, Jeyanthi, Hernandez‐Ilizaliturri, Francisco J., Chanan‐Khan, Asher, Czuczman, Myron S.

Volltext

Pro‐apoptotic therapy with the oligonucleotide GenasenseTM (oblimersen sodium) targeting Bcl‐2 protein expression enhances the biological anti‐tumour activity of rituximab von Ramanarayanan, Jeyanthi, Hernandez‐Ilizaliturri, Francisco J., Chanan‐Khan, Asher, Czuczman, Myron S.

Volltext